Our latest clinical trial is offering revolutionary new treatment for patients with adult congenital heart disease who would otherwise be facing at least a second surgical procedure. The Compassion Trial offers the leading edge technology, currently available for catheter-based aortic valve replacement, to patients with surgically repaired congenital heart disease who need pulmonary valve replacement. The Christ Hospital and The University of Kentucky Gill Heart Institute are the first healthcare providers in the region to offer the innovative procedure to patients. Watch the video to learn more about The Compassion Trial, who is eligible, and how you can enroll.